Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery
|ClinicalTrials.gov Identifier: NCT01558128|
Recruitment Status : Terminated (Insufficient Recruitment)
First Posted : March 20, 2012
Results First Posted : May 23, 2017
Last Update Posted : May 23, 2017
|Condition or disease||Intervention/treatment|
|Cardiac Disease||Drug: Amiodarone Procedure: Cardioversion|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery|
|Study Start Date :||March 2012|
|Primary Completion Date :||March 2013|
|Study Completion Date :||March 2013|
Amiodarone with cardioversion
If subject converts to normal sinus rhythm following amiodarone no further intervention is taken, if subject remains in atrial fibrillation following amiodarone they are cardioverted.
Bolus given 150mg IV, then IV drip 1mg per hour infused for 6 hours, 0.5mg per hour infused for 18 hours.
Other Name: CordaroneProcedure: Cardioversion
Cardioversion done if atrial fibrillation continues following 24 hour infusion of amiodarone. Cardioversion done following hospital protocol.
- Subject Rhythm [ Time Frame: Participants will be followed for the duration of their hospital stay post surgery with an expected average of 7 to 10 days and again at surgical follow up appointment up to 6 weeks. ]Measuring change from baseline cardiac rhythm.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01558128
|United States, New York|
|Weill Cornell Medical College|
|New York, New York, United States, 10065|
|Principal Investigator:||Gregory Kerr, MD||Weill Medical College of Cornell University|